Selective expression of CYP3A5 and not CYP3A4 in human blood

Pharmacogenetics

Volumn 6, Issue 5, 1996, Pages 379-385

  Janardan, Srinivas K ^a   Lown, Kenneth S ^a   Schmiedlin Ren, Phyllissa ^a   Thummel, Kenneth E ^b   Watkins, Paul B ^a,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Cytochrome P 450; Human; Leukocytes; Neutrophils

Indexed keywords

COMPLEMENTARY DNA; CYTOCHROME P450 ISOENZYME; ENZYME ANTIBODY; MESSENGER RNA; MIDAZOLAM; MONOCLONAL ANTIBODY; OLIGONUCLEOTIDE; POLYCLONAL ANTIBODY;

ARTICLE; BLOOD CELL; CONTROLLED STUDY; CYTOPLASM; DRUG METABOLISM; GENE AMPLIFICATION; GENE EXPRESSION; GENE SEQUENCE; GENOTYPE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KIDNEY; LIVER; MONONUCLEAR CELL; NEUTROPHIL; NORMAL HUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; VOLUNTEER;

CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; IMMUNOHISTOCHEMISTRY; MIXED FUNCTION OXYGENASES; NEUTROPHILS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE DISTRIBUTION;

ORYCTOLAGUS CUNICULUS;

EID: 0029836821     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199610000-00001     Document Type: Article

References (39)

1. Barnes TS, Shaw PM, Burke MD, Melvin WT. Monoclonal antibodies against human cytochrome P-450 recognizing different pregnenolone 16 alpha-carbonitrile-inducible rat cytochromes P-450. Biochem J 1987: 248, 301-304.
2. Beaune P, Kremers P, Letawe-Goujon F, Gielen JE. Monoclonal antibodies against human liver cytochrome P-450. Biochem Pharmacol 1985: 34, 3547-3552.
3. Beaune PH, Umbenhauer DR, Bork RW, Lloyd RS, Guengerich FP. Isolation and sequence determination of a cDNA clone related to human cytochrome P-450 nifedipine oxidase. Proc Natl Acad Sci USA 1986: 83, 8064-8068.
4. Becker EL. The short and happy life of neutrophil activation. J Leukoc Biol 1990: 47, 378-389.
5. Bork RW, Muto T, Beaune PH, Srivastava PK, Lloyd RS, Guengerich FP. Characterization of mRNA species related to human liver cytochrome P-450 nifedipine oxidase and the regulation of catalytic activity. J Biol Chem 1989: 264, 910-919.
6. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987: 162, 156-159.
7. Gillam EM, Guo Z, Ueng YF, Yamazaki H, Cock I, Reilly PE, Hooper WD, Guengerich FP. Expression of cytochrome P450 3A5 in Escherichia coli: effects of 5′ modification, purification, spectral characterization, reconstitution conditions, and catalytic activities [published erratum appears in Arch Biochem Biophys 1995: Apr 20; 318(2): 498]. Arch Biochem Biophys 1995: 317, 374-384.
8. Ginsburg I, Misgav R, Gibbs DF, Varani J, Kohen R. Chemiluminescence in activated human neutrophils: role of buffers and scavengers. Inflammation 1993: 17, 227-243.
9. Guengerich FP. Characterization of human cytochrome P450 enzymes. FASEB Journal 1992: 6, 745-748.
10. Kikuta Y, Kusunose E, Endo K, Yamamoto S, Sogawa K, Fujii-Kuriyama Y, Kusunose M. A novel form of cytochrome P-450 family 4 in human polymorphonuclear leukocytes. cDNA cloning and expression of leukotriene B4 omega-hydroxylase. J Biol Chem 1993: 268, 9376-9380.
11. Kolars JC, Schmiedlin-Ren P, Schuetz JD, Fang C, Watkins PB. Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes. J Clin Invest 1992: 90, 1871-1878.
12. Kolars JC, Benedict P, Schmiedlin-Ren P, Watkins PB. Aflatoxin B1-adduct formation in rat and human small bowel enterocytes. Gastroenterology 1994a: 106, 433-439.
13. Kolars JC, Lown KS, Schmiedlin-Ren P, Ghosh M, Fang C, Wrighton SA, Merion RM, Watkins PB. CYP3A gene expression in human gut epithelium. Pharmacogenetics 1994b: 4, 247-259.
14. Komori M, Nishio K, Fujitani T, Ohi H, Kitada M, Mima S, Itahashi K, Kamataki T. Isolation of a new human fetal liver cytochrome P450 cDNA clone: evidence for expression of a limited number of forms of cytochrome P450 in human fetal livers. Arch Biochem Biophys 1989: 272, 219-225.
15. Lown KS, Kolars JC, Thummel KE, Barnett JL, Kunze KL, Wrighton SA, Watkins PB. Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel: Lack of prediction by the erythromycin breath test [published erratum appears in Drug Metab Dispos 1995: 23: following table of contents]. Drug Metab Dispos 1994: 22, 947-955.
16. Lown KS, Thummel KE, Benedict PE, Shen DD, Turgeon DK, Berent S, Watkins PB. The erythromycin breath test predicts the clearance of midazolam. Clin Pharmacol Ther 1995: 57, 16-24.
17. McKinnon RA, Burgess WM, Hall PM, Abdul-Aziz Z, McManus ME. Metabolism of food-derived heterocyclic amines in human and rabbit tissues by P4503A proteins in the presence of flavonoids. Cancer Res (Suppl) 1992: 52, 2108s-2113s.
18. McKinnon RA, Burgess WM, Hall PM, Roberts-Thomson SJ, Gonzalez FJ, McManus ME. Characterization of CYP3A gene subfamily expression in human gastrointestinal tissues. Gut 1995: 36, 259-267.
19. Molowa DT, Schuetz EG, Wrighton SA, Watkins PB, Kremers P, Mendez-Picon G, Parker GA, Guzelian PS, Complete cDNA sequence of a cytochrome P-450 inducible by glycocorticoids in human liver. Proc Natl Acad Sci USA 1986: 83, 5311-5315.
20. Mungikar AM, Zingde SM, Advani SH, Gothoskar BP. Mixed function oxidase enzymes in human normal granulocytes and chronic myeloid leukemia cells. I. Detection and estimation. Biochem Med 1983: 30, 181-187.
21. Murray GI, Barnes TS, Sewell HF, Ewen SW, Melvin WT, Burke MD. The immunocytochemical localisation and distribution of cytochrome P-450 in normal human hepatic and extra-hepatic tissues with a monoclonal antibody to human cytochrome P-450. Br J Clin Pharmac 1988: 25, 465-475.
22. Murray GI, Pritchard S, Melvin WT, Burke MD. Cytochrome P450 CYP3A5 in the human anterior pituitary gland. FEBS Lett 1995: 364, 79-82.
23. Patton WN, Duffull SB, Idiosyncratic drug-induced haematological abnormalities. Incidence, pathogenesis, management and avoidance. Drug Saf 1994: 11, 445-462.
24. Pichard L, Fabre I, Fabre G, Domergue J, Saint Aubert B, Mourad G, Maurel P, Cyclosporin A Drug Interactions: Screening for inducers and inhibitors of cytochrome P450 (Cyclosporin A Oxidase) in primary cultures of human hepatocytes and in liver microsomes. Drug Metab Dispos 1990: 18, 595-606.
25. Roberts-Thomson SJ, McManus ME, Tukey RH, Gonzalez FJ, Holder GM. Metabolism of polycyclic aza-aromatic carcinogens catalyzed by four expressed human cytochromes P450. Cancer Res 1995: 55, 1052-1059.
26. Schuetz JD, Molowa DT, Guzelian PS. Characterization of a cDNA encoding a new member of the glucocorticoid-responsive cytochromes P450 in human liver. Arch Biochem Biophys 1989: 274, 355-365.
27. Schuetz EG, Schuetz JD, Grogan WM, Naray-Fejes-Toth A, Fejes-Toth G, Raucy J, Guzelian P, Gionela K, Watlington CO. Expression of cytochrome P450 3A in amphibian, rat, and human kidney. Arch Biochem Biophys 1992: 294, 206-214.
28. Schuetz JD, Guzelian PS, Isolation of CYP3A5P cDNA from human liver: a reflection of a novel cytochrome P-450 pseudogene. Biochim Biophys Acta 1995: 1261, 161-165.
29. Shimada T, Guengerich FP, Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver. Proc Natl Acad Sci USA 1989: 86, 462-465.
30. Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 1994: 270, 414-423.
31. Thummel KE, Shen DD, Podoll TD, Kunze KL, Trager WF, Hartwell PS, Raisys VA, Marsh CL, McVicar JP, Barr DM, Perkins JD, Carithers RL. Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-in vivo correlations in liver transplant patients. J Pharmacol Exp Ther 1994: 271, 549-556.
32. Turgeon DK, Normolle DP, Leichtman AB, Annesley TM, Smith DE, Watkins PB. Erythromycin breath test predicts oral clearance of cyclosporine in kidney transplant recipients. Clin Pharmacol Ther 1992: 52, 471-478.
33. Turgeon DK, Leichtman AB, Lown KS, Normolle DP, Deeb GM, Merion RM, Watkins PB, P450 3A activity and cyclosporin dosing in kidney and heart transplant recipients. Clin Pharmacol Ther 1994: 56, 253-260.
34. Watkins PB, Wrighton SA, Schuetz EG, Molowa DT, Guzelian PS. Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man. J Clin Invest 1987: 80, 1029-1036.
35. Watkins PB, Hamilton TA, Annesley TM, Ellis CN, Kolars JC, Voorhees JJ. The erythromycin breath test as a predictor of cyclosporine blood levels. Clin Pharmacol Ther 1990: 48, 120-129.
36. Watkins PB. Drug metabolism by cytochromes P450 in the liver and small bowel. Gastroenterology Clinics of NA 1992: 21, 511-526.
37. Watkins PB. Noninvasive tests of CYP3A enzymes. Pharmacogenetics 1994: 4, 171-184.
38. Wrighton SA, Vandenbranden M. Isolation and characterization of human fetal liver cytochrome P450HLp2: A third member of the P450III gene family. Arch Biochem Biophys 1989: 268, 144-151.
39. Wrighton SA, Brian WR, Sari MA, Iwasaki M, Guengerich FP, Raucy JL, Molowa DT, Vandenbranden M. Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3). Mol Pharmacol 1990: 38, 207-213.